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We report 3 cases of Queensland tick typhus (QTT) 
and 1 case of African tick bite fever in which the causative 
rickettsiae were detected by PCR of eschar and skin lesions 
in all cases. An oral mucosal lesion in 1 QTT case was also 
positive.    
Q
ueensland tick typhus (QTT) is endemic to Sydney, 
New  South  Wales,  Australia  (1–6).  A  prospective 
study of 80 serologically confirmed QTT cases (63 acquired 
in Sydney) yielded 68 cases with rash, of which 62% and 
27%, respectively, were vesicular and pustular (6). This 
study yielded an isolate of Rickettsia australis from a pa-
tient who acquired QTT in Sydney (1). Eschar biopsies 
and removed eschars have been used for PCR confirmation 
of rickettsial and scrub typhus infections (7). We report 3 
cases of QTT and 1 case of African tick bite fever (ATBF) 
in which the causative rickettsiae were detected by PCR of 
eschar and skin lesions in all cases and by an oral mucosal 
lesion in one of the QTT cases. Clinical details of the cases 
are summarized below. 
The Cases 
Case 1
A 45-year-old woman sought treatment at the emer-
gency department in one of our district hospitals after being 
bitten by a tick in suburban Sydney. Clinical signs were 
inguinal  eschar,  tender  local  lymphadenopathy,  fever  to 
39.8°C, severe headache, myalgia, arthralgia, and general-
ized sparse rash characterized by maculopapular and ve-
siculopustular lesions. 
Case 2
A 32-year-old woman, a resident of suburban Sydney, 
sought treatment for an acute febrile illness (fever to 41°C), 
severe headache, myalgia, arthralgia, and rash. She did not 
recall a tick bite. Clinical examination showed an eschar on 
the torso, generalized sparse rash characterized by macu-
lopapular and vesiculopustular lesions, plus oral mucosal 
lesions and a palatal lesion. 
Case 3
A 79-year-old woman sought treatment for gradual on-
set of fever (to 38.8°C) after being bitten by a tick at her 
home in suburban Sydney. Examination showed an eschar 
on the scalp, tender local lymphadenopathy, and general-
ized rash with maculopapular and vesicular components. 
In these 3 cases, acute-phase serologic results were 
negative; convalescent-phase serologic results yielded an 
R. australis indirect fluorescent antibody (IFA) titer of 512. 
Illness resolved completely after treatment with doxycy-
cline, 100 mg 2×/day, for 14 days. 
Case 4
A  57-year-old  man  with  gradual  onset  of  fever  (to 
38.8°C) sought treatment 10 days after visiting a game park 
in South Africa. He did not recall a tick bite. Clinical exam-
ination showed an eschar on the torso, tender local lymph-
adenopathy, and generalized sparse rash characterized by 
papular and vesiculopustular lesions. Illness resolved com-
pletely after a regimen of doxycycline, 100 mg 2×/day. R. 
australis IFA acute titer was <128; titer for serum collected 
44 days after fever onset was 128. R. africae antigen was 
unavailable for IFA. Acute-phase and convalescent-phase 
serum samples were negative for R. typhi and Orientia tsut-
sugamushi (all IFA titers <128). 
Specimens on all 4 cases were collected as shown in 
the Table. Serologic analysis was performed by using the 
reference method of IFA testing using R. australis infect-
ed cells, according to Philip et al (8). Total antibody to R. 
australis was detected. A titer of 128 was regarded as bor-
derline; titers >128 were regarded as positive. To confirm 
recent infection, a 4-fold rise in titer is preferre . 
For PCR, specimens were collected by swab of eschar 
margin or, in the case of unroofed vesicular lesions, in the 
manner described by Rawls (9). Copan Amies Transport 
swab without charcoal and Copan Virus Transport swab 
(Interpath Services, Melbourne, Victoria, Australia) were 
used. Duplicates were collected from the same lesion in 
some cases; 1 specimen was collected using a dry swab, 
and another by using a sterile saline moistened swab. 
Identification of Rickettsia spp. citrate synthase-encod-
ing gene (gltA) PCR was performed based on the method 
of Roux et al. (10). DNA was extracted from the specimens 
by using the QIAamp DNA Mini kit (QIAGEN, Doncaster, 
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col. Positive control was R. australis DNA extracted from 
3–5-day-old Vero cell culture, serially diluted from 1:10 
to 1:105. Extraction blanks, consisting of water processed 
along with the specimens, were also included as negative 
controls. 
Eppendorf  DNA  Thermalcycler  (Eppendorf,  North 
Ryde, New South Wales, Australia) was used for all PCR 
amplification. Five microliters of each DNA extraction was 
added to 45 µL of master mixture for each reaction. Final 
reagent concentration was 10 pmol for each primer, 200 
µM for each deoxynucleotide triphosphate, 1 U of Ampli-
Taq Gold DNA Polymerase (Applied Biosystems, Roche 
Molecular System, Inc., Indianapolis, IN, USA), and 1× 
PCR buffer. The following thermal cycler parameters were 
used with the primer pairs for the gltA gene RpCS.877p and 
Rp1273r primers, which amplify a 397-bp portion of the 
gltA gene from all Rickettsia spp.: 95°C (10 min), followed 
by 40 cycles of 95°C (30 s), 45°C (30 s), and 72°C (55 s), 
followed by an extension period (72°C, 10 min). 
The  amplicons  were  detected  after  electrophoresis 
on a 4% agarose gel stained with ethidium bromide and 
purified using the QIAquick DNA Purification kit (QIA-
GEN)  for  sequencing  analysis.  BLAST  (www.ncbi.nlm.
nih.gov/BLAST) was used for comparison and analysis of 
sequence data obtained. PCR-positive specimens on QTT 
cases yielded sequences 99% homologous with R. australis 
(Phillips strain). Amplification was unsuccessful in all neg-
ative controls. PCR results for herpes simplex and varicella 
zoster viruses were both negative on the swab of the palatal 
lesion. PCR-positive specimens on the ATBF case yielded 
sequences that were 99% homologous with R. africae. Gen-
Bank accession nos. for sequences are EU543436 (case 1 
eschar); EU543438 (case 2 palatal lesion); EU543438 (case 
3 vesicular lesion); and EU714268 (case 4 eschar). 
PCR results for blood specimens were negative in all 
cases. For QTT cases, all eschars yielded positive PCR 
results for R. australis, irrespective of type of swab used. 
Vesicle swabs also yielded positive PCR results for R. aus-
tralis but only in cases 1 and 3. In case 2, the palatal le-
sion yielded a positive PCR result for R. australis. For the 
ATBF case, all vesicular lesions and eschar swabs yielded 
a positive PCR result for R. africae. 
Based on previous reports and recommendations, tis-
sue collected from the eschar site is the most likely speci-
men to provide a positive result for rickettsia PCR or cul-
ture (11,12). Lepidi et al. (13) reported 8 cases of ATBF 
wherein age of eschars at biopsy ranged from 5 to 10 days. 
Of 8 eschar biopsies, positive results were obtained by im-
munohistochemical analysis (IHC) (6/8), serologic analy-
sis (4/8), culture (4/8), regular PCR (6/8), and nested PCR 
(8/8). Although we did not use nested PCR, we still had 
100% detection of rickettsiae in 4 eschars of similar ages 
and after up to 4 doses of doxycycline, 100 mg. Eschar scab 
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Table. PCR results by specimen, relation to clinical signs, and doses of doxycycline taken, Australia*  
Case no.  Specimen type
Duration of 
lesion, d 
Duration of 
fever, d 
No. 100-mg 
doxycycline doses PCR result
1
  EDTA   Blood, EDTA  NA 3 2
  Eschar   Eschar, Amies, dry  6 3 2
  Eschar   Eschar, virus, dry  6 3 2 +
  Vesicle   Vesicle, virus, dry  6 3 2 +
  Vesicle   Vesicle, virus, dry  7 4 4 –
2
  Blood   Blood, EDTA  NA 3 0 –
  Eschar   Eschar, Amies, dry  6 3 0 +
  Eschar   Eschar, virus, dry  8 5 0 +
  Eschar   Eschar, virus, saline  10 7 4 +
  Vesicle   Vesicle, Amies, dry  1 3 0 –
  Vesicle   Vesicle, virus, dry  3 5 0 –
  Vesicle   Vesicle, virus, saline  5 7 4 –
  Palatal lesion   Lesion, virus, dry  5 7 4 +
3
  Blood   Blood, EDTA  NA 1 0 –
  Eschar   Eschar, virus, saline  10 2 1 +
  Vesicle   Vesicle, virus, saline  6 2 1 +
4
  Blood   Blood, EDTA  NA 5 2 –
  Eschar   Eschar, virus, dry  10 5 2 +
  Vesicle   Vesicle, virus, dry  4 5 2 +
  Vesicle   Vesicle, virus, dry  4 5 2 +
*NA, not applicable.  Queensland Tick Typhus and African Tick Bite Fever 
in scrub typhus yielded positive nested PCR result for O. 
tsutsugamushi in a child 7 days after commencement of 
treatment with azithromycin (7). 
Accordingly, eschar specimens may permit character-
ization of the causative organism even after days of anti-
microbial drug therapy. In the cases we studied, no blood 
specimens were positive by the PCR method used; swabs 
of all eschars and some vesicular skin lesions were positive. 
Rickettsemia may not be detected by any method because 
of variables such as stage of illness, effective antimicrobial 
drug therapy, individual variation in level of rickettsemia, 
and sensitivity of the detection method. We acknowledge 
that insufficient numbers of rickettsiae for detection by the 
PCR method used may have resulted in some false negative 
results. Real-time PCR methods likely offer greater sen-
sitivity while also providing quantitative data. Addition-
ally, PCR-negative lesions may have been positive by IHC, 
which when used in conjunction with PCR, has improved 
rickettsiae detection in skin biopsies (12). 
Eschar or vesicular skin lesion swab has high patient 
acceptance because the test is simple and virtually painless. 
Although lesion biopsy enables IHC (and improved rick-
ettsiae detection), our results justify further exploration of 
swab PCR to confirm diagnosis of QTT, ATBF, and other 
rickettsial spotted fevers.   
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